ArticleJournal of clinical medicine2023

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse.

Tim Flaadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.